Wendy Stock to Follow-Up Studies
This is a "connection" page, showing publications Wendy Stock has written about Follow-Up Studies.
Connection Strength
0.259
-
Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL. Blood. 2024 04 18; 143(16):1616-1627.
Score: 0.036
-
Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the Childhood Cancer Survivor Study. Lancet Oncol. 2020 03; 21(3):421-435.
Score: 0.027
-
Outcomes of Allogeneic Stem Cell Transplantation after Inotuzumab Ozogamicin Treatment for Relapsed or Refractory Acute Lymphoblastic Leukemia. Biol Blood Marrow Transplant. 2019 09; 25(9):1720-1729.
Score: 0.025
-
Inotuzumab ozogamicin versus standard of care in relapsed or refractory acute lymphoblastic leukemia: Final report and long-term survival follow-up from the randomized, phase 3 INO-VATE study. Cancer. 2019 07 15; 125(14):2474-2487.
Score: 0.025
-
Outcome for pediatric acute promyelocytic leukemia patients at Children's Oncology Group sites on the Leukemia Intergroup Study CALGB 9710 (Alliance). Pediatr Blood Cancer. 2019 03; 66(3):e27542.
Score: 0.024
-
A Phase 2 Trial of Fludarabine Combined With Subcutaneous Alemtuzumab for the Treatment of Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia. Clin Lymphoma Myeloma Leuk. 2015 Nov; 15(11):694-8.
Score: 0.019
-
Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma. Leukemia. 2015 Oct; 29(10):2113-6.
Score: 0.019
-
Ultrasonic endoluminal examination in the follow-up of colorectal cancer. Initial experience and results. Int J Colorectal Dis. 1990 Dec; 5(4):188-94.
Score: 0.014
-
A Phase II study of Bcl-2 antisense (oblimersen sodium) combined with gemtuzumab ozogamicin in older patients with acute myeloid leukemia in first relapse. Leuk Res. 2006 Jul; 30(7):777-83.
Score: 0.010
-
Treatment of the chronic phase of chronic myeloid leukemia with an intermittent schedule of recombinant interferon alfa-2b and cytarabine: results from CALGB study 9013. Leuk Lymphoma. 2003 Jan; 44(1):39-48.
Score: 0.008
-
Allogeneic blood cell transplantation following reduced-intensity conditioning is effective therapy for older patients with myelofibrosis with myeloid metaplasia. Blood. 2002 Mar 15; 99(6):2255-8.
Score: 0.008
-
Progressive transformation of germinal centers. Report of 2 cases and review of the literature. Acta Haematol. 2002; 108(1):33-8.
Score: 0.008
-
[Acceptance and effectiveness of surgical vascular consultation--is it worthwhile?]. Chirurg. 1995 Dec; 66(12):1239-44; discussion 1245-6.
Score: 0.005
-
[Long-term outcome of the donor site after free, microvascular pedicled iliac crest transplantation: experiences with 95 cases]. Handchir Mikrochir Plast Chir. 1995 Sep; 27(5):233-41.
Score: 0.005
-
[Is the surgeon a prognostically relevant factor after R0-resection of colorectal carcinoma?]. Chirurg. 1995 Apr; 66(4):334-42; discussion 342-3.
Score: 0.005
-
[Results of regular follow-up after removal of colorectal adenomas]. Med Klin (Munich). 1993 Aug 15; 88(8):471-7.
Score: 0.004
-
Does methodic long-term follow-up affect survival after curative resection of colorectal carcinoma? Dis Colon Rectum. 1993 Mar; 36(3):280-6.
Score: 0.004
-
[Inguinal hernia repair modified by Kirschner. A critical analysis after 11 years of clinical experience]. Langenbecks Arch Chir. 1992; 377(6):324-31.
Score: 0.004
-
[Follow-up in stomach carcinoma]. Leber Magen Darm. 1991 Mar; 21(2):68, 71-4.
Score: 0.004
-
[Individual risk-related after-care in colorectal cancer?]. Langenbecks Arch Chir. 1991; 376(6):314-22.
Score: 0.004
-
[Surgical treatment of large thoracic wall recurrences in breast cancer]. Chirurg. 1987 Sep; 58(9):607-11.
Score: 0.003